Logo

SurroMed Takes License to Ingenuity Pathway Analysis Application

Dec 08, 2003

NEW YORK, Dec. 8 (GenomeWeb News) - SurroMed said today that it has licenced Ingenuity Systems' Pathway Analysis, an application that maps relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases.

 

Financial terms of the arrangement were not disclosed.

 

Ingenuity has recently licensed the Pathways Analysis system to the  Genomics Institute of the Novartis Research Foundation, the  Stanford Genome Technology Center, and  GlaxoSmithKline, and recently signed a software distribution  deal with investor Affymetrix.

Breaking News
The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.